LOADING
Comparing NVIDIA Corporation (NVDA) and Johnson & Johnson (JNJ) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | JNJ |
|---|---|---|
| Price | $233.59 | $230.17 |
| Change Today | +3.43% | -0.11% |
| Market Cap | $5.49T | $554.7B |
| P/E Ratio | 46.1 | 26.7 |
| Forward P/E | 26.5 | 19.1 |
| PEG Ratio | 0.68 | 2.88 |
| EPS | $4.90 | $8.64 |
| Revenue Growth (YoY) | 73.2% | 9.9% |
| Profit Margin | 55.6% | 21.8% |
| Return on Equity | 101.5% | 26.4% |
| Dividend Yield | 0.02% | 2.32% |
| Beta | 2.24 | 0.26 |
| 52-Week High | $227.84 | $251.71 |
| 52-Week Low | $129.13 | $145.18 |
| Volume | 2.8M | 67K |
NVIDIA Corporation is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.